1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
Cellectis - ADR
XNAS: CLLS
1.51 -0.02 (-1.31%)
88,887

XNAS 21 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Cellectis (ADR) - CLLS - stock price prediction, stock price target, analyst ratings from 5 analysts

Cellectis (ADR) has a share price target of US$ 5, revenue growth forecast of -32.6%, and profit growth estimate of -22.3% for FY26, based on top 5 analyst calls.